OCGN

Ocugen, Inc. Common Stock
Data: 2026-08-07

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Quick Stats
Aug 07, 2026

51.7

AI Score

HOLD

0.62

Volume Ratio

Aug 06, 2026

Next Earnings

10

+ve Days (30d)

17

-ve Days (30d)

OCGN Stock Summary

Last updated Aug 07, 2026

OCGN is currently trading at $1.28, positioned below its 200-day moving average of $1.52, suggesting bearish momentum. The stock has a 52-week range of $0.945 to $2.725.

Technical Analysis: The 50-day moving average stands at $1.34, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 46.483, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.244, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates OCGN at 51.7/100 with a HOLD recommendation.

OCGN (Ocugen, Inc. Common Stock) Indicators

Last updated Aug 07, 2026

Indicator Value
RSI(14) 46.483
CMF (20) -0.244
ROC (10) 5.785
ADX (14) 20.421
Indicator Value
MACD (12,26,9) -0.036
AROONOSC (14) -50.0
WILLAMS %R (14) -38.889
MFI (14) 48.706
OCGN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

OCGN Price vs Max Options Open Interest
OCGN Max Change In Options Open Interest

OCGN Options - Sort by Max open Interest (near term)

8th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OCGN Daily Out of Money Options - Sort by Max open Interest (near term)

8th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OCGN Daily In the Money Options - Sort by Max open Interest (near term)

8th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OCGN Most Active Options by Volume(near term)

8th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Ocugen, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

OCGN Moving Averages Analysis

OCGN (Ocugen, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 07, 2026

Days MA
10 1.25
20 1.3
30 1.37
50 1.34
100 1.53
200 1.52

OCGN Fundamental Analysis

P/E (Forward) 13.0719
P/E (Trailing) --
Market Cap ($) 420.5 million
Earnings/Share ($) -0.23
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.22
EPS Estimate Next Year ($) -0.2333
WallStreet Target Price ($) 12.17
Most Recent Quarter